Evidence map›Paper›PMID 39554582›Full record

ArticleJournal of gastrointestinal oncology2024

Construction of diagnostic models with machine-learning algorithms for colorectal cancer based on clinical laboratory parameters.

Dengqing Si, Yu Shu, Hongbo Jiang, Xueping Lin, Qiurong Yuan, Shaotuan Deng, Wei Luo, Yangze Lin, Ju Wang, Chengxiong Zhan and 4 more

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dengqing Si *Department of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Yu Shu *Department of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Hongbo JiangDepartment of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Xueping Lin *Department of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Qiurong YuanDepartment of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Shaotuan DengDepartment of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Wei LuoShenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Yangze LinShenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Ju WangShenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Chengxiong ZhanShenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Aasma ShaukatDivision of Gastroenterology, NYU Grossman School of Medicine, New York, NY, USA.
Peter C AmbeDepartment of Surgery II, Witten/Herdecke University, Witten, Germany.
Shiqiong NiuDepartment of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Zhaofan LuoDepartment of Clinical Medical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colonoscopy remains the predominant diagnostic modality for colorectal cancer (CRC), as the diagnostic performance of tumor markers in alone, particularly in the early stages of the disease, is limited. This study sought to develop a diagnostic model for CRC that integrated various laboratory parameters. Methods: One hundred patients with CRC were assigned to an experimental group while 114 with benign colorectal diseases and 101 healthy individuals were assigned to a control group. The clinical and laboratory data, including the tumor markers such as carcinoembryonic antigen (CEA), glycan carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 242 (CA242), blood count parameters, blood biochemical parameters, and coagulation parameters, were collected for each participant. Three machine-learning models [multilayered perceptron (MLP), eXtreme Gradient Boosting (XGBoost), and random forest (RF)] were used to construct CRC diagnostic models. The performance of each model was evaluated based on its area under the curve (AUC), sensitivity, and specificity. Results: There are 12 parameters: including CEA, CA19-9, CA242, absolute neutrophil value (NEUT), hemoglobin, the neutrophil/lymphocyte ratio, the platelet/lymphocyte ratio, alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, albumin, and prothrombin time, were selected to build the diagnostic model. For the validation set, the RF machine-learning model achieved the highest performance in identifying CRC [AUC: 0.902 (95% confidence interval: 0.812-0.989), accuracy: 0.803, sensitivity: 0.908, specificity: 0.772, positive predictive value: 0.664, negative predictive value: 0.890, and F1 score: 0.763]. The AUC, sensitivity, specificity, and Youden's index for the combined diagnosis of tumor markers CEA, CA19-9, and CA242 were 0.761, 0.486, 0.983, and 0.469, respectively. The RF diagnostic model showed better diagnostic efficacy than the combined diagnosis model of tumor markers CEA, CA19-9 and CA242. Conclusions: The use of machine learning combined with multiple laboratory parameters effectively improved the diagnostic efficiency of CRC and provided more accurate results for clinical diagnosis.

Indexed as

Colorectal cancer (CRC)diagnostic modelmachine learningtumor markers

Identifiers

PMID39554582
PMCPMC11565110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.